Advisory - Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
OTTAWA, Nov. 15, 2019 /CNW/ - Health Canada is advising Canadians that Duchesnay Inc. is recalling certain lots of PregVit vitamin-mineral supplements (for prenatal and postpartum use) and PregVit folic 5 vitamin-mineral supplements (for prenatal use) because blister packages may contain all pink (morning) tablets instead of the correct combination of pink and blue (evening) tablets. The company estimates the issue affects a very small number of products in certain lots (see the table below) and not all products.
There are no quality, safety or effectiveness concerns with the tablets themselves but there is the potential that patients may not take the proper combination of pink and blue tablets if they have received products impacted by the packaging error.
The pink and the blue tablets do not contain the same active ingredients. Women taking all pink tablets will not receive the intended vitamin and mineral supplements. In particular, the pink tablets do not contain folic acid, which is important for the healthy growth of an unborn baby and helps to reduce some types of birth defects called neural tube defects.
Properly packaged products should contain two blister packs, with each blister pack containing 15 pink tablets and 15 blue tablets. The company received a complaint of a product containing a blister pack that contained all pink tablets and no blue tablets.
Who is affected Women who have bought or are using the affected products.
Affected products
Product
DIN
Lot
Expiry
PregVit
Format 60
02451573
19003
2021-10-31
19001V
2021-09-30
18015V
2021-08-31
18010V
2021-05-31
18012V
2021-04-30
18006V
2020-08-31
18003V
2020-06-30
17019V
2020-05-31
17016
2020-07-31
17002
2020-03-31
16065
2020-02-29
16064
2020-01-31
16045
2019-12-31
16042
2019-12-31
PregVit folic 5
Format 60
02451581
18022
2021-07-31
18007
2020-10-31
18002
2020-09-30
16053
2019-12-31
What consumers should do
Check your product to make sure it contains the correct combination of pink and blue tablets (each blister pack should contain 15 pink and 15 blue tablets [see photos]).
Continue taking the prescribed number of pink and blue tablets per day as directed by your health care professional. If your product has an incorrect tablet combination, talk to your pharmacist about obtaining a replacement. Properly packaged products do not need to be returned.
Consult your health care professional if you have used either of these products and have health concerns.
Contact Duchesnay Inc. by calling toll-free at 1-888-666-0611, or by email at [email protected], if you have any questions about the recall.
Check packages of PregVit and PregVit folic 5 before dispensing them to patients.
Not all lots are being recalled. While the company has put a verification process in place to make sure that products not impacted by this recall are properly packaged, checking products before dispensing provides an added safeguard.
What Health Canada is doing Health Canada is monitoring the recall and verifying that the company has effectively addressed the packaging issue. Should additional safety concerns be identified, Health Canada will take appropriate action and inform Canadians as necessary.
The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024.
A distinguished medical researcher, Dr. Nemer has served as Canada's...
The "TechVision50: Top 50 Advanced and Emerging Technologies" report has been added to ResearchAndMarkets.com's offering.
TechVision50 is a guide of the 50 greatest opportunities in Advanced Technologies and Materials at the mid-point of 2024. This...
The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral...
The "The Worldwide Market for Clinical Laboratory Services, 9th Edition" report has been added to ResearchAndMarkets.com's offering.
Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers...
The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug...
Health providers from the Registered Nurses' Association of Ontario's (RNAO) Best Practice Spotlight Organizations® (BPSO®) will meet in Thunder Bay for an inaugural knowledge-sharing event. Hosted by RNAO and developed with BPSOs, the...